Educated Patient® Kidney Cancer Summit Combination Therapy Panel: April 9, 2022 This panel featured Dr. Thomas Hutson, Dr. Saby George, Dr. Jeff Yorio, and Louise Gunter.

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of an ultrasound renal ...

Please provide your email address to receive an email when new articles are posted on . An FDA panel voted that for adults with uncontrolled hypertension, the benefits of a radiofrequency renal ...

This panel was moderated by Kristie L. Kahl and featured Dr. Thomas Hutson, Louise Gunter and Meryl Uranga. Kahl: I want to shift gears to talk about side effects and dose reductions. So Louise, I ...

Professor of Medicine at Harvard Medical School and Senior Investigator in the Section on Genetics and Epidemiology at Joslin Diabetes Center in Boston, MA. To facilitate translational research on ...

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel has deemed the ReCor Paradise Ultrasound Renal Denervation (uRDN) System safe and effective in lowering blood pressure ...

The US Food and Drug Administration's (FDA's) Circulatory System Devices Panel unanimously agreed that the Symplicity Spyral Renal Denervation System (Medtronic, Inc.) is safe, but the panel was split ...

Advisors on the US Food and Drug Administration’s Circulatory System Devices Panel voted today in support of the premarket approval (PMA) application for the Paradise Ultrasound Renal Denervation ...

Hemotransfusion in treatment of anemia, 3D illustration showing two populations of red blood cells, small hypochromic red blood cells and normal. A small lymphocyte is drawn for size comparison The ...

A radiofrequency-based renal denervation system for uncontrolled hypertension got a cool reception from FDA advisors who nevertheless left the door open for regulatory approval. On Wednesday, the ...

The Paradise ultrasound renal denervation system got backing from the FDA's Circulatory System Devices Panel as a possible treatment for hypertension, as manufacturer ReCor continues to hope for ...

General laboratory evaluation. Typical post-transplant monitoring labs are shown in Table 2. KDIGO suggests (with low evidence of support) that labs be obtained two to three times per week for weeks 2 ...